Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Masked inherited primary arrhythmia syndromes in sudden cardiac death patients accompanied by coronary vasospasm.

Lee KH, Park HW, Eun JN, Cho JG, Yoon NS, Kim MR, Ku YH, Park H, Lee SH, Kim JH, Kim MC, Kim WJ, Kim HK, Cho JY, Park KH, Sim DS, Yoon HJ, Kim KH, Hong YJ, Kim JH, Ahn Y, Jeong MH, Park JC.

Korean J Intern Med. 2017 Sep;32(5):836-846. doi: 10.3904/kjim.2015.283. Epub 2017 Aug 11.

2.

Biodegradable Cable-Tie Rapamycin-eluting Stents.

Lee CH, Hsieh MJ, Chang SH, Chiang CL, Fan CL, Liu SJ, Chen WJ, Wang CJ, Hsu MY, Hung KC, Chou CC, Chang PC.

Sci Rep. 2017 Mar 8;7(1):111. doi: 10.1038/s41598-017-00131-w.

3.

Statin non-adherence: clinical consequences and proposed solutions.

Rosenson RS.

F1000Res. 2016 Apr 21;5. pii: F1000 Faculty Rev-714. doi: 10.12688/f1000research.8215.1. eCollection 2016. Review.

4.

Rosuvastatin Reduces Blood Viscosity in Patients with Acute Coronary Syndrome.

Jung LY, Lee SR, Jung JM, Kim YS, Lee SH, Rhee KS, Chae JK, Lee DH, Kim DS, Kim WH, Ko JK.

Korean Circ J. 2016 Mar;46(2):147-53. doi: 10.4070/kcj.2016.46.2.147. Epub 2016 Mar 21.

5.

Impact of Urate Level on Cardiovascular Risk in Allopurinol Treated Patients. A Nested Case-Control Study.

Søltoft Larsen K, Pottegård A, Lindegaard HM, Hallas J.

PLoS One. 2016 Jan 11;11(1):e0146172. doi: 10.1371/journal.pone.0146172. eCollection 2016.

7.

A Case of Statin-Induced Interstitial Pneumonitis due to Rosuvastatin.

Kim SY, Kim SJ, Yoon D, Hong SW, Park S, Ock CY.

Tuberc Respir Dis (Seoul). 2015 Jul;78(3):281-5. doi: 10.4046/trd.2015.78.3.281. Epub 2015 Jun 30.

8.

Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study.

Ashrani AA, Barsoum MK, Crusan DJ, Petterson TM, Bailey KR, Heit JA.

Thromb Res. 2015 Jun;135(6):1110-6. doi: 10.1016/j.thromres.2015.04.005. Epub 2015 Apr 11.

9.

Effects of simvastatin treatment on serum adiponectin concentrations in patients with dislipidemia.

Moezzi A, Parizadeh SM, Tavallaie S, Mazidi M, Afzali F, Adab A, Ferns G, Ghayour Mobarhan M.

Iran Red Crescent Med J. 2014 Aug;16(8):e6915. doi: 10.5812/ircmj.6915. Epub 2014 Aug 5.

10.

Modulation of the mevalonate pathway by akt regulates macrophage survival and development of pulmonary fibrosis.

Larson-Casey JL, Murthy S, Ryan AJ, Carter AB.

J Biol Chem. 2014 Dec 26;289(52):36204-19. doi: 10.1074/jbc.M114.593285. Epub 2014 Nov 5.

11.

Promoting endothelial recovery and reducing neointimal hyperplasia using sequential-like release of acetylsalicylic acid and paclitaxel-loaded biodegradable stents.

Lee CH, Yu CY, Chang SH, Hung KC, Liu SJ, Wang CJ, Hsu MY, Hsieh IC, Chen WJ, Ko YS, Wen MS.

Int J Nanomedicine. 2014 Aug 27;9:4117-33. doi: 10.2147/IJN.S67721. eCollection 2014.

12.
13.

Thiazolidinedione-independent activation of peroxisome proliferator-activated receptor γ is a potential target for diabetic macrovascular complications.

Matsumura T, Taketa K, Shimoda S, Araki E.

J Diabetes Investig. 2012 Feb 20;3(1):11-23. doi: 10.1111/j.2040-1124.2011.00182.x. Review.

14.

Cerebral blood flow velocity and vasomotor reactivity during autonomic challenges in heart failure.

Serber SL, Rinsky B, Kumar R, Macey PM, Fonarow GC, Harper RM.

Nurs Res. 2014 May-Jun;63(3):194-202. doi: 10.1097/NNR.0000000000000027.

15.

Effects of atorvastatin 10 mg/d on insulin resistance: A 12-week, open-label study in hyperlipidemic patients.

Ozerkan F, Ozdogan O, Zoghi M, Nalbantgil S, Yavuzgil O, Remzi Önder M.

Curr Ther Res Clin Exp. 2006 Jan;67(1):44-54. doi: 10.1016/j.curtheres.2006.02.002.

16.

Perioperative evaluation of cardiac surgical risk: particularities in the emergency surgery - from the guidelines to the clinical practice.

Andronescu AM, Nechita AC, Ittu G, Delcea C, Dumitrescu G, Vintila MM.

J Med Life. 2013 Sep 15;6(3):310-5. Epub 2013 Sep 25.

17.

Amelioration of cisplatin-induced nephrotoxicity by statins.

Maheshwari RA, Sailor GU, Patel L, Balaraman R.

Indian J Pharmacol. 2013 Jul-Aug;45(4):354-8. doi: 10.4103/0253-7613.115016.

18.
19.

Elevated levels of procoagulant plasma microvesicles in dialysis patients.

Burton JO, Hamali HA, Singh R, Abbasian N, Parsons R, Patel AK, Goodall AH, Brunskill NJ.

PLoS One. 2013 Aug 2;8(8):e72663. doi: 10.1371/journal.pone.0072663. Print 2013.

20.

Statins in heart failure: do we need another trial?

Bonsu KO, Kadirvelu A, Reidpath DD.

Vasc Health Risk Manag. 2013;9:303-19. doi: 10.2147/VHRM.S44499. Epub 2013 Jun 17. Review.

Supplemental Content

Support Center